First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM
- PMID: 21807978
- PMCID: PMC3186983
- DOI: 10.1128/AAC.00341-11
First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM
Abstract
Achromobacter xylosoxidans is an emerging pathogen in cystic fibrosis patients. The multidrug resistance of these bacteria remains poorly understood. We have characterized in a clinical strain the first resistance-nodulation-cell division (RND)-type multidrug efflux pump in this species: AxyABM. The inactivation of the transporter component axyB gene led to decreased MICs of cephalosporins (except cefepime), aztreonam, nalidixic acid, fluoroquinolones, and chloramphenicol.
Figures
References
-
- Aisenberg G., Rolston K. V., Safdar A. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003). Cancer 101:2134–2140 - PubMed
-
- Almuzara M., et al. 2010. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. Int. J. Antimicrob. Agents 35:68–71 - PubMed
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
